The only peer-reviewed journal dedicated to cellular reprogramming mechanisms, technologies, and applications. Formerly as Cloning and Stem Cells, Est. 1999.
This year, we are celebrating the 25 years launching anniversary of our journal (formerly as Cloning and Stem Cells)!
In March 1999, Mary Ann Liebert launched the journal with Sir Ian Wilmut as editor-in-chief after the achievement of cloning Dolly the sheep.
Induction of Neuronal Differentiation of Human Dermal Mesenchymal Stem Cells by a Defined Arginine-Aspartate-Phenylalanine Peptide Mixture in Vitro | Cellular Reprogramming https://t.co/EEz7EgNh6j
Reprogramming Stars #25: Modeling Brain Aging with Direct Reprogramming of Skin Cells into Neurons—An Interview with Dr. Jerome Mertens | Cellular Reprogramming https://t.co/Mhv3jEWu7b
Transformation of an Olfactory Placode-Derived Cell into One with Stem Cell Characteristics by Disrupting Epigenetic Barriers Ehmt2. https://t.co/HZM5Psd4c0
1/2 The interview series "Reprogramming Stars" featured in Cellular Reprogramming, highlights the work of leaders in the field by introducing them and their science in exciting talks. @CellRepJrnl
Article: Menstrual Blood-Derived Mesenchymal Stem Cells (MenSCs) rescue implantation failure in a mifepristone-induced mouse model, highlighting their potential as a novel treatment: https://t.co/f5G1K26bfL
New article from @eghbalsaied group: Editing the CYP19 Gene in Goat Embryos Using CRISPR/Cas9 and Somatic Cell Nuclear Transfer Techniques
https://t.co/DKXPEZRvvW
FIG. 5. Scientific research has demonstrated that FSH and relaxin exert a significant influence on the differentiation of SCs by modulating the ERK1/2 and PI3k/Akt signaling pathways.
🧬 Working on optimizing a #stemcell or #celldifferentiation protocol but unsure where to publish? 🤔 We encourage you to submit your protocol to us! 📄 Our journal welcomes innovative methodologies in stem cell research—share your advancements with the scientific community!
Our journal also promotes transparency in cellular reprogramming research and related fields through the publication of confirmatory studies, adverse events and negative data. Send us your cellular reprogramming paper and receive a first decision within 20 days!
Submit Today with Zero Submission Fees!
Cellular Reprogramming is currently seeking high-quality innovative manuscripts to be published in future issues.
New Article Alert: Highly Defined Induced Pluripotent Stem Cell Lines Mimic Donor Red Blood Cell Antigen Profiles for Therapeutic and Diagnostic Use https://t.co/fk4qxcLUHD